receptors, safety indexes, inhibition Flashcards

1
Q

nicotinic acetylcholine receptor type?

A

ligand-gated sodium channel with receptor and conformational change allowing sodium to pass through

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is GR?

A

cytosolic hormone receptor, has DNA binding domain, translocates to nucleus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

discuss the nature of chemical bonding of ligand to receptor

A
  • most are H bond or van der waals
  • antagonists are often covalent
  • all non-covalents eventually dissociate and this marks the end of drug action
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

the magnitude of a drug response is a function of:

A

concentration of drug-receptor complexes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

explain the two types of dose response curve

A

1) quantal - all or none, LD50 and ED50, population not individual, sigmoidal
2) continual/graded - individual only, also usually sigmoidal,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are ED, TD, and LD?

A
  • ED - effective dose
  • TD - toxic dose
  • LD - lethal dose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is the therapeutic index (TI) and what should we know about it?

A
  • LD50/ED50
  • should be greater than 1 and the bigger the better
  • limited because it looks at midpoint so you can’t tell from it if there is an LD/ED overlap
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is the margin of safety index (MI) and what should we know about it?

A
  • LD1/ED99
  • conservative, compares extremes
  • should be greater than 1 and bigger is better
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the protective index (PI) and what should we know about it?

A
  • ED50 undesirable / ED50 desirable
  • should be greater than 1 and bigger is better
  • used to separate desired from undesired effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is the chronicity index (CI) and what should we know about it?

A
  • one-dose LD50 / ninety-dose LD50
  • 1 is best (total clearance), 90 is worst (no clearance)
  • ## measuring cumulative toxicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is a threshold dose?

A

an apparent all or none phenomenon at the physiological level when administering progressively higher doses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is the difference between potency and intrinsic activity?

A
  • higher potency means reaching desired effect at lower dose

- intrinsic activity means the highest desired effect a drug can obtain regardless of dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

affinity vs efficacy

A

affinity is measured by the k1/k2, association and dissociation of ligand with receptor, whereas efficacy is measured by k3, the rate of effect of the ligand-receptor complex on the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is chemical antagonism?

A

direct interaction of the agonist and antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is functional antagonism?

A

two agonists act independently but have opposite effects, best example is SANS vs PANS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is competitive antagonism and what are the two types of competitive antagonists?

A
  • antagonist binds to receptor but elicits no response (high affinity but no efficacy)
    1) equilibrium - reversible
    2) non-equilibrium - irreversible
17
Q

what happens to dose response curve of agonist in the presence of increasing equilibrium antagonist?

A

shifts to the right but stays the same shape

18
Q

what happens to dose response curve of agonist in the presence of increasing non-equilibrium antagonist?

A

curve flattens out

19
Q

what is non-competitive antagonism?

A

antagonist acts at site other than where agonist binds

20
Q

what happens to the dose response curve of agonist in the presence of non-competitive antagonist?

A

curve flattens - same as non-equilibrium antagonist

21
Q

what is a partial agonist?

A
  • has low intrinsic activity

- in combination with an agonist it can act as either an agonist or antagonist

22
Q

additivity

A
  • effects of two drugs are additive
23
Q

synergy

A
  • effect of combined drugs is higher than their two individual effects added together.
24
Q

simple synergy vs potentiation

A
  • simple synergy is as previous described, potentiation is when one drug that seemingly does very little on its own can dramatically affect another drug